12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial

Bernadette Ann-Marie O'Hare; REALITY Trial Team

doi:10.7448/IAS.19.6.21264

12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial

Bernadette Ann-Marie O'Hare, REALITY Trial Team

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa
Publisher	John Wiley & Sons, Ltd
Pages	101-101
Number of pages	1
Volume	19
DOIs	https://doi.org/10.7448/IAS.19.6.21264
Publication status	Published - Jul 2016
Event	21st International AIDS Conference (AIDS 2016) - Durban, South Africa Duration: 18 Jul 2016 → 22 Jul 2016 Conference number: 21 https://www.aids2016.org/

Publication series

Name	Journal of the International AIDS Society
Publisher	INT AIDS SOCIETY
ISSN (Print)	1758-2652

Conference

Conference	21st International AIDS Conference (AIDS 2016)
Abbreviated title	AIDS 2016
Country/Territory	South Africa
City	Durban
Period	18/07/16 → 22/07/16
Internet address	https://www.aids2016.org/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7448/IAS.19.6.21264Licence: CC BY

Cite this

O'Hare, B. A.-M., & REALITY Trial Team (2016). 12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial. In Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (Vol. 19, pp. 101-101). Article FRAB0102LB (Journal of the International AIDS Society). John Wiley & Sons, Ltd. https://doi.org/10.7448/IAS.19.6.21264

O'Hare, Bernadette Ann-Marie ; REALITY Trial Team. / 12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children : the REALITY trial. Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Vol. 19 John Wiley & Sons, Ltd, 2016. pp. 101-101 (Journal of the International AIDS Society).

@inproceedings{235c14a3192443feba348be5dc1db362,

title = "12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial",

author = "C. Kityo and A. Siika and Szubert, \{A. J.\} and J. Mallewa and M. Bwakura-Dangarembizi and S. Kabahenda and S. Mwaringa and Pett, \{S. L.\} and A. Griffiths and A. Lugemwa and S. Wachira and G. Musoro and C. Rajapakse and T. Etyang and J. Abach and P. Wavamunno and L. Nyondo-Mipando and A. Reid and K. Nathoo and J. Hakim and Gibb, \{D. M.\} and Walker, \{A. S.\} and O'Hare, \{Bernadette Ann-Marie\} and \{REALITY Trial Team\}",

year = "2016",

month = jul,

doi = "10.7448/IAS.19.6.21264",

language = "English",

volume = "19",

series = "Journal of the International AIDS Society",

publisher = "John Wiley \& Sons, Ltd",

pages = "101--101",

booktitle = "Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa",

address = "United States",

note = "21st International AIDS Conference (AIDS 2016), AIDS 2016 ; Conference date: 18-07-2016 Through 22-07-2016",

url = "https://www.aids2016.org/",

}

O'Hare, BA-M & REALITY Trial Team 2016, 12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial. in Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. vol. 19, FRAB0102LB, Journal of the International AIDS Society, John Wiley & Sons, Ltd, pp. 101-101, 21st International AIDS Conference (AIDS 2016), Durban, South Africa, 18/07/16. https://doi.org/10.7448/IAS.19.6.21264

12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial. / O'Hare, Bernadette Ann-Marie; REALITY Trial Team.
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Vol. 19 John Wiley & Sons, Ltd, 2016. p. 101-101 FRAB0102LB (Journal of the International AIDS Society).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - 12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children

T2 - 21st International AIDS Conference (AIDS 2016)

AU - Kityo, C.

AU - Siika, A.

AU - Szubert, A. J.

AU - Mallewa, J.

AU - Bwakura-Dangarembizi, M.

AU - Kabahenda, S.

AU - Mwaringa, S.

AU - Pett, S. L.

AU - Griffiths, A.

AU - Lugemwa, A.

AU - Wachira, S.

AU - Musoro, G.

AU - Rajapakse, C.

AU - Etyang, T.

AU - Abach, J.

AU - Wavamunno, P.

AU - Nyondo-Mipando, L.

AU - Reid, A.

AU - Nathoo, K.

AU - Hakim, J.

AU - Gibb, D. M.

AU - Walker, A. S.

AU - O'Hare, Bernadette Ann-Marie

AU - REALITY Trial Team

N1 - Conference code: 21

PY - 2016/7

Y1 - 2016/7

U2 - 10.7448/IAS.19.6.21264

DO - 10.7448/IAS.19.6.21264

M3 - Conference contribution

VL - 19

T3 - Journal of the International AIDS Society

SP - 101

EP - 101

BT - Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

PB - John Wiley & Sons, Ltd

Y2 - 18 July 2016 through 22 July 2016

ER -

O'Hare BAM, REALITY Trial Team. 12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial. In Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Vol. 19. John Wiley & Sons, Ltd. 2016. p. 101-101. FRAB0102LB. (Journal of the International AIDS Society). Epub 2016 Jul 22. doi: 10.7448/IAS.19.6.21264